- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0045992

Salus Laboratories Private Limited
About Salus Laboratories Private Limited
Data last updated:
Salus Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 18 February 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC042674. Its GSTIN is 36AAICS1250P1Z0 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹78 Lakh and a paid-up capital of ₹66 Lakh. It is led by directors Rajasekhar Tammineedi and Adinarayana Kamma.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.B – 85 Flat No. G – 100 Mallareddy Towers, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.59 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹23.98 Lakh (net margin 2.3%) and EBITDA of ₹80.87 Lakh (EBITDA margin 7.6%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 12% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Salus Lab. As per MCA filings, the company has satisfied charges of ₹1.89 Cr on record.
Salus Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0045992). The current compliance status is marked as compliant by the Registrar of Companies.
CIN History of Salus Laboratories Private Limited
Salus Laboratories has one previous CIN (Corporate Identification Number): U24239AP2004PTC042674. The current CIN is U24239TG2004PTC042674, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC042674 | Current |
| U24239AP2004PTC042674 | Previous |
Recognitions & Rankings of Salus Laboratories
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.B – 85 Flat No. G – 100 Mallareddy Towers, Hyderabad, Telangana, India – 500038
- IndustryFMCG, Personal Care & Skincare Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Salus Laboratories Private Limited
Salus Laboratories operates one associated brand: Salus Lab. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers cyber security services including offensive, defensive, and awareness training. | saluslab.net |
Business Activity of Salus Laboratories Private Limited
The main business activity of Salus Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Salus Laboratories Private Limited FY 2025 filings available
Salus Laboratories Private Limited reported revenue of ₹10.59 Cr (up 45% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Salus Laboratories Private Limited
Revenue rose 45% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Salus Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹80.87 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹23.98 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Salus Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Salus Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Salus Laboratories Private Limited
Salus Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajasekhar Tammineedi | Director | 18 Feb 2004 | 22 Years 8 Months | Current |
| Adinarayana Kamma | Director | 25 Feb 2007 | 19 Years 7 Months | Current |
Peer Comparison of Salus Laboratories Private Limited
Salus Laboratories Private Limited is compared with the companies closest to it by revenue in the FMCG industry (Formulations, Personal Care and Skin Care). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Renovate Biologicals Private Limited | ₹10.63 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mahabubnagar, Telangana, India |
| Infinitee India Naturals and Synthetics Private Limited | ₹10.63 Cr (FY 2024) | •••• | •••• | 71.0% | •••• | Koparkhairne, Maharashtra, India |
| Vista Pharmaceuticals Ltd. Listed | ₹10.62 Cr (FY 2024) | •••• | •••• | 657.0% | •••• | Telangana, India |
| Kuemen Laboratories Private Limited | ₹10.6 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | New Delhi, Delhi, India |
| Pharmtech Solutions Private Limited | ₹10.59 Cr (FY 2019) | •••• | •••• | 397.0% | •••• | Hyderabad, Telangana, India |
| Salus Laboratories Private Limited this company | ₹10.59 Cr (FY 2024) | •••• | •••• | 45.0% | •••• | Hyderabad, Telangana, India |
| Biowin Healthcare Limited | ₹10.57 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Ahmedabad, Gujarat, India |
| Pureca Laboratories Private Limited | ₹10.57 Cr (FY 2022) | •••• | •••• | -57.0% | •••• | Delhi, India |
| Juice Cosmetics Private Limited | ₹10.53 Cr (FY 2025) | •••• | •••• | 3009957.0% | •••• | Mumbai, Maharashtra, India |
| Dallas Formulations Private Limited | ₹10.53 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Ujjain, Madhya Pradesh, India |
| Ram Lal Inder Lal Private Limited | ₹10.52 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Salus Laboratories by revenue in the FMCG industry (Formulations, Personal Care and Skin Care), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Salus Laboratories Private Limited
Salus Laboratories Private Limited is audited by ESWARAIAH & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ESWARAIAH & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Salus Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Salus Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2022 | Bank of India | ₹20 Lakh | Satisfied |
| 20 Jul 2022 | Bank of India | ₹69 Lakh | Satisfied |
| 18 Mar 2005 | A.P. State Finnacial Corporation | ₹1 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Salus Laboratories Private Limited
Salus Laboratories Private Limited has a workforce of 23 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Salus Laboratories Private Limited
Salus Laboratories Private Limited has 3 board changes on record since 2004: 2 appointments and 1 cessation. The latest: Venkateswara Rao Talluri Satya ceased to be Director on 27 Mar 2010.
Credit Ratings, Litigation & Regulatory Alerts for Salus Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Salus Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Salus Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Salus Laboratories Private Limited
Salus Laboratories has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICS1250P1Z0 | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Salus Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Salus Laboratories Private Limited
Salus Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 18 February 2004 (22+ years old) and is registered under CIN U24239TG2004PTC042674.
Salus Laboratories reported revenue of ₹10.59 Cr for FY 2024 (up 45% YoY).
Salus Laboratories has 2 current directors:
- Rajasekhar Tammineedi - Director
- Adinarayana Kamma - Director
Salus Laboratories reported a net profit of ₹23.98 Lakh (net margin 2.3%) and EBITDA of ₹80.87 Lakh (EBITDA margin 7.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Salus Laboratories is -24% over three years and -12% over five years. In the latest year (FY 2024) revenue rose 45%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Salus Laboratories is 36AAICS1250P1Z0, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Salus Laboratories is U24239TG2004PTC042674. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Salus Laboratories was incorporated on 18 February 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Salus Laboratories by revenue are Renovate Biologicals Private Limited, Infinitee India Naturals and Synthetics Private Limited, Vista Pharmaceuticals Ltd, Kuemen Laboratories Private Limited, Pharmtech Solutions Private Limited and 5 more, all in the FMCG industry (Formulations, Personal Care and Skin Care).
Venkateswara Rao Talluri Satya ceased to be Director on 27 Mar 2010. Adinarayana Kamma was appointed as Director on 25 Feb 2007. Rajasekhar Tammineedi was appointed as Director on 18 Feb 2004.
Yes, Salus Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0045992).